Tom was instructed by Claire Stoneman and Nicola Rawlinson-Weller of Foot Anstey LLP in a claim arising out of the tragic death caused by arrhythmic sudden cardiac death attributable to atherosclerotic coronary disease. In the preceding weeks, the Deceased had been on standard treatment for acute coronary syndrome following a suspected heart attack; the treatment included the regular administration of Clopidrogel, Bisoprolol (a beta-blocker), Ramipril and Simvastatin.